• LAST PRICE
    0.3950
  • TODAY'S CHANGE (%)
    Trending Up0.0271 (7.3661%)
  • Bid / Lots
    0.3810/ 10
  • Ask / Lots
    0.3998/ 39
  • Open / Previous Close
    0.3952 / 0.3679
  • Day Range
    Low 0.3700
    High 0.4000
  • 52 Week Range
    Low 0.3200
    High 9.6100
  • Volume
    560,456
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.3679
TimeVolumeTCBP
09:32 ET169910.399799
09:33 ET115880.3701
09:35 ET17600.3837
09:37 ET21900.3781
09:39 ET42980.3837
09:42 ET76700.386849
09:44 ET61800.389899
09:46 ET33980.3864
09:48 ET11000.3897
09:50 ET4500.38297
09:51 ET61000.3789
09:55 ET2600.3801
09:57 ET18000.3801
10:00 ET1350.38
10:04 ET23010.386
10:08 ET9470.3789
10:09 ET31660.37
10:11 ET13000.3878
10:15 ET5000.38
10:18 ET40000.3801
10:20 ET10000.3801
10:22 ET20380.3801
10:24 ET59930.3801
10:27 ET70800.386
10:29 ET3500.3701
10:31 ET40460.3781
10:36 ET312000.3712
10:38 ET54280.38
10:42 ET44000.3759
10:44 ET27500.381499
10:45 ET33000.3759
10:49 ET20000.3703
11:09 ET47490.3704
11:12 ET401300.386
11:16 ET452440.383
11:18 ET37400.383
11:21 ET11000.387799
11:23 ET8100.3839
11:25 ET10000.384
11:27 ET6580.38395
11:30 ET46520.384
11:34 ET4000.3844
11:36 ET9000.3859
11:38 ET2030.3855
11:39 ET29000.3849
11:43 ET52000.3849
11:45 ET2000.3859
11:50 ET338830.3844
11:59 ET4000.39
12:01 ET11000.39
12:06 ET1000.385
12:14 ET108000.385
12:15 ET24260.389029
12:17 ET10200.3855
12:19 ET2630.385
12:21 ET9970.389509
12:24 ET20000.385001
12:28 ET12730.3897
12:33 ET3160.3875
12:35 ET336880.38
12:37 ET12680.385
12:39 ET20000.39
12:48 ET73600.3875
12:50 ET25230.389
12:51 ET47680.387
12:55 ET1000.3852
01:04 ET30020.3997
01:06 ET10000.399799
01:08 ET6600.399699
01:09 ET25000.3851
01:13 ET179300.3918
01:20 ET18000.3918
01:22 ET3600.3918
01:24 ET1000.394249
01:26 ET13000.393999
01:31 ET1600.3975
01:40 ET27720.3901
01:45 ET1000.3901
01:47 ET144330.3881
01:56 ET9940.3901
02:00 ET2830.39418
02:07 ET3000.3876
02:09 ET61110.385
02:16 ET1000.385001
02:30 ET5000.3912
02:32 ET1000.39
02:34 ET100000.3899
02:41 ET15140.387499
02:45 ET82900.39
02:54 ET65850.385
02:57 ET28210.385
03:08 ET170000.39
03:12 ET2560.39
03:15 ET3000.3875
03:19 ET63500.39
03:32 ET41400.3901
03:33 ET10080.390201
03:35 ET6000.3973
03:37 ET27580.3851
03:39 ET75520.3912
03:46 ET1000.3851
03:48 ET4500.3852
03:50 ET13700.3885
03:51 ET42480.394
03:55 ET27850.395
03:57 ET211670.3999
04:00 ET10750.395
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTCBP
TC BioPharm Ltd
3.4M
0.0x
---
United StatesPTPI
Petros Pharmaceuticals Inc
3.5M
-0.2x
---
United StatesSTMM
Stemcell Holdings Inc
1.6M
750.0x
---
United StatesPULM
Pulmatrix Inc
7.5M
-0.5x
---
United StatesFRTX
Fresh Tracks Therapeutics Inc
5.0M
-0.3x
---
United StatesQLGN
Qualigen Therapeutics Inc
3.7M
-0.2x
---
As of 2023-12-02

Company Information

TC BioPharm Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma-delta T cell therapies for the treatment of infectious disease. The Company's platform technology allows the Company to design specific therapies to treat a range of cancers and infectious diseases with off-the-shelf allogeneic gamma-delta T cell (GDT) products. The Company’s pipeline includes OmnImmune and CAR-T programs. OmnImmune is an unmodified allogeneic gamma-delta T cell product being used for the treatment of acute myeloid leukemia (AML). The Company has completed a Phase II clinical trial. Its CAR-T programs include in-house and partner programs at the pre-clinical-stage focused on developing CAR modified allogeneic gamma delta T-cell products targeting solid and hematological indications.

Contact Information

Headquarters
Maxim 1, 2 Parklands WayHONITON, United Kingdom ML1 4WR
Phone
141-433-7557
Fax
---

Executives

Chief Executive Officer
Michael Leek
Chief Financial Officer
Martin Thorp
Chief Operating Officer
Angela Scott
Company Secretary
Toby Rintoul
Director
Bryan Kobel

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.4M
Revenue (TTM)
$3.6M
Shares Outstanding
936.4K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-17.33
Book Value
$-0.13
P/E Ratio
0.0x
Price/Sales (TTM)
1.0
Price/Cash Flow (TTM)
---
Operating Margin
-416.57%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.